Insider Purchases: Inside the Buy
Tag: long term investing
📈 Hamilton Lane (HLNE): The Toll Booth on a Trillion-Dollar Private Markets Highway
Hamilton Lane (HLNE) may be one of the most attractive alternative asset managers on the market today. Massive insider buying, a growing dividend, a trillion-dollar asset footprint, and expanding private-wealth opportunities combine to create a compelling long-term investment story.
🩺 GE HealthCare (GEHC): Insider Buying, AI Growth & a $21B Backlog Opportunity
GE HealthCare (GEHC) is quietly shaping up as a high-visibility MedTech play, combining insider buying, a $21.8B backlog, and AI-driven diagnostics. With valuation still reasonable and institutional ownership near record levels, this could be a compelling long-term compounder—if you’re patient on entry.
KKR: The Private Equity Giant Offering Public-Scale Prosperity
KKR is no longer just for billionaires in wood-paneled boardrooms. With insiders buying, earnings compounding, and shares still ~38% below highs, the private equity giant looks like public-scale opportunity.
Insider Buys AAON’s Cool Air and Open Windows: Should You Be a Fan?
AAON is cooling data centers — and heating up investor debate. With insider buying, record backlog, and AI-driven demand tailwinds, the business looks strong. The stock? Still pricey. Let’s break it down — helmet on. ❄️🪖
Apple CEO & Nike Director Tim Cook Buys Shares: Is NKE Ready to Sprint?
Nike is down nearly 70% from its peak — but insiders are stepping in. When Apple CEO and Nike director Tim Cook buys nearly $3 million worth of shares, it raises an interesting question: is the swoosh warming up for a comeback sprint?
Director Purchases Shares of Johnson & Johnson
A director just slapped fresh cash on Johnson & Johnson stock. With a AAA credit rating, a 100+ year history, blockbuster drugs, cutting-edge MedTech, and a valuation that’s more “fair” than “fire sale,” should retail investors follow—or wait for a better entry point?
Investor & Insider James Breyer Just Bought Blackstone (BX). Should You Sip the Alt-Assets Kool-Aid—or Sit It Out?
Blackstone remains the alt-assets apex predator: $1.24T AUM, rising perpetual capital, and a fresh insider buy from director James Breyer. We unpack fundraising momentum, distributable earnings, variable dividends, key risks (rates, exits), and why dips may be gifts for long-term investors.